Announcements Trials

Browse Landscape

Phase

Phase 2 16 Phase 1 10 Phase 1/2 4 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1

Conditions

Hodgkin Disease 1

Interventions

Rituximab 238 Cyclophosphamide 192 Vincristine 164 Doxorubicin 150 Prednisone 126 Methotrexate 80 Cytarabine 79 Etoposide 78 Dexamethasone 72 Radiotherapy 60 Bendamustine Hydrochloride 58 Mercaptopurine 46 Lenalidomide 42 pegaspargase 41 Prednisolone 38 Filgrastim 38 ibrutinib 37 fludarabine 36 Bleomycin 36 Daunorubicin 35 obinutuzumab 34 Asparaginase 33 Leucovorin 29 venetoclax 28 Granulocyte Colony-Stimulating Factor 28 Chlorambucil 27 Calcium Dobesilate 27 Gemcitabine 26 Vinblastine 25 Thioguanine 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Panobinostat × Lymphoid × Clear all

NCT01034163 2016-07-07

PATH

Novartis

Phase 3 Completed

41 enrolled 7 charts

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡